Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Sep 20

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Sep 20

DOI: 10.23736/S0026-4806.21.07777-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Severe aortic stenosis and transcatheter aortic valve replacement in elderly patients: utility vs futility

Pierfranco TERROSU 1 , Alessandro BOCCANELLI 1, Giuseppe SABINO 2, Paolo ALBONI 1, Samuele BALDASSERONI 1, Mario BO 1, Giovambattista DESIDERI 1, Niccolò MARCHIONNI 1, Giuseppe PALAZZO 1, Renzo ROZZINI 1, Andrea UNGAR 1, Francesco VETTA 1, Giovanni ZITO 1

1 SICGe - Società Italiana di Cardiologia Geriatrica, Firenze, Italy; 2 UOC di Cardiologia, AOU-Ospedale SS. Annunziata, Sassari, Italy


PDF


INTRODUCTION: Recently, transcatheter aortic valve replacement (TAVR) has emerged as established standard treatment for symptomatic severe aortic stenosis, providing an effective, less-invasive alternative to open cardiac surgery for inoperable or high-risk older patients.
EVIDENCE ACQUISITION: In order to assess the anticipated benefit of aortic replacement, considerable interest now lies in better identifying factors likely to predict outcome. In the elderly population frailty and medical comorbidities have been shown to significantly predict mortality, functional recovery and quality of life after transcatheter aortic valve replacement. Scientific literature focused on the three items will be discussed.
EVIDENCE SYNTHESIS: High likelihood of futility is described in patients with severe chronic lung, kidney, liver disease and/or frailty. The addition of frailty components to conventional risk prediction has been shown to result in improved discrimination for death and disability following the procedure and identifies those individuals least likely to derive benefit. Several dedicated risk score have been proposed to provide new insights into predicted “futile” outcome. However, assessment of frailty according to a limited number of variables is not sufficient, while a multi-dimensional geriatric assessment significantly improves risk prediction.
CONCLUSIONS: A multidisciplinary heart team that includes geriatricians can allow the customization of therapeutic interventions in elderly patients to optimise care and avoid futility.


KEY WORDS: Transcatheter aortic valve replacement; Frailty; Older adults

top of page